Redwood Investment Management LLC Decreases Position in HCA Healthcare, Inc. $HCA

Key Points

• Redwood Investment Management LLC has reduced its position in HCA Healthcare by 37.5%, now holding 10,693 shares, valued at approximately $3.7 million.
• HCA Healthcare reported an impressive quarterly earnings per share (EPS) of $6.84, exceeding analysts' expectations and indicating a revenue increase of 6.4% year-over-year.
• The company declared a quarterly dividend of $0.72 per share with a yield of 0.7%, reflecting a dividend payout ratio of 12.11%.

Redwood Investment Management LLC cut its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 37.5% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 10,693 shares of the company's stock after selling 6,414 shares during the quarter. Redwood Investment Management LLC's holdings in HCA Healthcare were worth $3,695,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Samalin Investment Counsel LLC acquired a new stake in shares of HCA Healthcare in the 1st quarter worth $218,000. Virtus Advisers LLC acquired a new stake in shares of HCA Healthcare during the 1st quarter worth about $110,000. Ally Financial Inc. increased its position in shares of HCA Healthcare by 50.0% during the 1st quarter. Ally Financial Inc. now owns 4,500 shares of the company's stock worth $1,555,000 after purchasing an additional 1,500 shares during the last quarter. Comerica Bank increased its position in shares of HCA Healthcare by 2.0% during the 1st quarter. Comerica Bank now owns 36,571 shares of the company's stock worth $12,637,000 after purchasing an additional 715 shares during the last quarter. Finally, ICONIQ Capital LLC acquired a new stake in shares of HCA Healthcare during the 1st quarter worth about $312,000. 62.73% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of analysts recently issued reports on HCA shares. Royal Bank Of Canada cut their price objective on HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating for the company in a research report on Monday, July 28th. JPMorgan Chase & Co. raised their target price on HCA Healthcare from $360.00 to $370.00 and gave the company a "neutral" rating in a report on Monday, August 4th. Wolfe Research cut HCA Healthcare from an "outperform" rating to a "peer perform" rating in a report on Monday, July 28th. Robert W. Baird raised their target price on HCA Healthcare from $380.00 to $423.00 and gave the company a "neutral" rating in a report on Thursday, August 14th. Finally, Cantor Fitzgerald restated an "overweight" rating and set a $444.00 target price on shares of HCA Healthcare in a report on Tuesday. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and nine have issued a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $401.83.

HCA Healthcare Stock Up 0.6%

Shares of HCA traded up $2.50 during midday trading on Thursday, hitting $407.55. The company had a trading volume of 965,359 shares, compared to its average volume of 1,154,093. The company's 50-day simple moving average is $376.38 and its 200-day simple moving average is $356.08. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.86 and a current ratio of 0.98. The firm has a market capitalization of $95.36 billion, a P/E ratio of 17.13, a P/E/G ratio of 1.27 and a beta of 1.39. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.20 by $0.64. The business had revenue of $18.61 billion during the quarter, compared to analysts' expectations of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The business's quarterly revenue was up 6.4% compared to the same quarter last year. During the same quarter last year, the business posted $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, sell-side analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be paid a dividend of $0.72 per share. The ex-dividend date is Tuesday, September 16th. This represents a $2.88 annualized dividend and a yield of 0.7%. HCA Healthcare's payout ratio is presently 12.11%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.